Breaking News Instant updates and real-time market news.

SDRL

Seadrill

$16.68

0.45 (2.77%)

, TSCO

Tractor Supply

$94.15

-1.62 (-1.69%)

16:19
11/14/18
11/14
16:19
11/14/18
16:19

Greenlight enters Seadrill, Tractor Supply and Michael Kors during Q3

David Einhorn's Greenlight Capital disclosed in a regulatory filing its holdings as of September 30, 2018. Greenlight made five new buys during the third quarter, including by size of position, Seadrill (SDRL), Tractor Supply (TSCO), Sherwin-Williams (SHW) and Michael Kors (KORS). The fund exited 14 positions during the quarter, including by size of previous position, Mylan (MYL), Twitter (TWTR), Apple (AAPL), Micron Technology (MU) and Clipper Realty (CLPR). Greenlight increased its stake in two holdings, IAC (IAC) and Adient (ADNT). The fund reduced its stake in seven holdings, including by size General Motors (GM), Perrigo (PRGO), Voya Financial (VOYA), The Medicines Co. (MDCO) and AerCap Holdings (AER). Greenlight's top holdings as of September 30, in order of size, were General Motors, Green Brick Partners (GRBK), AerCap, Ensco (ESV) and Voya Financial.

SDRL

Seadrill

$16.68

0.45 (2.77%)

TSCO

Tractor Supply

$94.15

-1.62 (-1.69%)

SHW

Sherwin-Williams

$414.80

-2.04 (-0.49%)

KORS

Use CPRI

$47.99

-0.24 (-0.50%)

MYL

Mylan

$34.23

-1.53 (-4.28%)

TWTR

Twitter

$32.92

0.43 (1.32%)

AAPL

Apple

$186.81

-5.42 (-2.82%)

MU

Micron

$38.03

0.17 (0.45%)

CLPR

Clipper Realty

$14.00

-0.05 (-0.36%)

IAC

IAC

$180.60

-4.9 (-2.64%)

ADNT

Adient

$24.13

-0.36 (-1.47%)

GM

General Motors

$35.23

-0.7 (-1.95%)

PRGO

Perrigo

$63.47

-1.98 (-3.03%)

VOYA

Voya Financial

$45.04

-0.46 (-1.01%)

MDCO

The Medicines Co.

$20.82

-1.97 (-8.64%)

AER

AerCap

$51.85

-0.06 (-0.12%)

GRBK

Green Brick

$8.70

-0.15 (-1.69%)

ESV

Symbol changed to VAL

$6.15

0.1 (1.65%)

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 28

    Nov

SDRL Seadrill
$16.68

0.45 (2.77%)

10/24/18
BTIG
10/24/18
INITIATION
Target $35
BTIG
Buy
Seadrill initiated with a Buy at BTIG
BTIG analyst Gregory Lewis initiated Seadrill with a Buy and $35 price target. Lewis said with utilization on the upswing for both jackups and floaters and some signs of pricing improvement for both, believes we are in the early days of an offshore drilling recovery.
06/01/18
GHSC
06/01/18
UPGRADE
Target $18
GHSC
Buy
Ship Finance upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Magnus Fyhr upgraded Ship Finance (SFL) to Buy with a $18 price target saying risk/reward is increasingly attractive with several potential catalysts developing over the next few months, combined with the Seadrill (SDRL) restructuring already reflected in estimates. Fyhr said the company has ample dry powder to pursue accretive acquisitions and the current backlog provides cash flow visibility and dividend support.
10/25/18
10/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Seadrill (SDRL) initiated with a Buy at BTIG. 2. Resideo (REZI) initiated with an Outperform at Oppenheimer. 3. Magnolia Oil & Gas (MGY) initiated with an Overweight at MUFG. 4. Athenex (ATNX) initiated with a Buy at Ladenburg. 5. Zumiez (ZUMZ) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TSCO Tractor Supply
$94.15

-1.62 (-1.69%)

10/26/18
RBCM
10/26/18
UPGRADE
Target $105
RBCM
Outperform
Tractor Supply upgraded to Outperform at RBC Capital on comp and ticket growth
As reported earlier, RBC Capital analyst Scot Ciccarelli upgraded Tractor Supply to Outperform from Sector Perform and raised his price target to $105 from $87. The analyst states that questions lingered after the company's "incrementally bullish" analyst meetings in July, but the Q3 results mark the second straight quarter of "5%+ comp/3.5%+ ticket growth". The analyst expects the solid comp trends to continue in the near to medium term, with more "confidence" building on margins heading into 2019.
10/26/18
WEDB
10/26/18
UPGRADE
WEDB
Outperform
Tractor Supply upgraded to Outperform from Neutral at Wedbush
10/26/18
10/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tractor Supply (TSCO) upgraded to Outperform from Sector Perform at RBC Capital, to Outperform from Neutral at Wedbush, and to Neutral from Underperform at BofA/Merrill. 2. Twitter (TWTR) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying he believes within the scope of Social Media, Twitter shares offer reasonable value with reduced execution risk. 3. First Solar (FSLR) upgraded to Market Perform from Underperform at JMP Securities with analyst Joseph Osha citing valuation following the stock's 35% decline since the end of May. 4. GrubHub (GRUB) upgraded to Conviction Buy from Buy at Goldman Sachs, to Buy from Neutral at DA Davidson, and to Buy from Hold at Stifel. 5. Six Flags (SIX) upgraded to Neutral from Underperform at Macquarie with analyst Matthew Brooks saying he believes negative catalysts have passed and valuation is more balanced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/18
WEDB
10/26/18
UPGRADE
Target $100
WEDB
Outperform
Tractor Supply upgraded to Outperform from Neutral at Wedbush
Wedbush analyst Seth Basham upgraded Tractor Supply to Outperform from Neutral and raised his price target for shares to $100 from $80 following the company's "solid" Q3 beat. In a research note to investors, Basham says Tractor Supply's near-term outlook is favorable, and sees 80+ bps of margin pressure in 2018 dissipating, while it is positioned to implement newly-formed plans for efficiencies in the supply chain, indirect procurement and labor management that could be worth 100+ bps to margins over time. Basham believes consensus margin forecasts for 2019 appear too low, particularly if Chinese tariff rates do not rise further and the macro outlook only moderately slows.
SHW Sherwin-Williams
$414.80

-2.04 (-0.49%)

10/16/18
EDJN
10/16/18
UPGRADE
EDJN
Buy
Sherwin-Williams upgraded to Buy from Hold at Edward Jones
Edward Jones analyst Matt Arnold upgraded Sherwin-Williams to Buy from Hold.
10/10/18
10/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Vipshop (VIPS) downgraded to Neutral from Overweight at JPMorgan with analyst Alex Yao saying as the "tough competitive environment and harder-than-expected synergy generation," Vipshop is likely to adjust its strategy to re-focus on core off-season apparel distribution and prioritize profitability over sales growth. 2. International Paper (IP) downgraded to Neutral from Buy at Goldman Sachs while WestRock (WRK) was downgraded to Buy from Conviction Buy. 3. Clorox (CLX), Church & Dwight (CHD), and Kimberly-Clark (KMB) were downgraded to Sell from Hold at Deutsche Bank. 4. Sherwin-Williams (SHW) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying "tough" market comments from companies like H.B. Fuller (FUL), PPG (PPG) and RPM (RPL) suggest that coatings companies are likely to be challenged by rising raw materials costs and slowing growth in key end markets, including China. 5. KKR (KKR) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/18
SBSH
10/10/18
DOWNGRADE
Target $435
SBSH
Neutral
Citi downgrades Sherwin-Williams after 'tough' comments from peers
Citi analyst P.J. Juvekar downgraded Sherwin-Williams (SHW) to Neutral from Buy and lowered his price target for the shares to $435 from $492. "Tough" market comments from companies like H.B. Fuller (FUL), PPG (PPG) and RPM (RPL) suggest that coatings companies are likely to be challenged by rising raw materials costs and slowing growth in key end markets, including China, Juvekar tells investors in a research note. Despite a strong U.S. stores business, Sherwin-Williams is not immune to these risks, especially with Valspar's more cyclical industrial business and acquisition-related debt, the analyst contends.
10/29/18
GSCO
10/29/18
UPGRADE
Target $124
GSCO
Conviction Buy
PPG upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Robert Koort added PPG Industries (PPG) to his firm's Conviction List while keeping a Buy rating on the shares with a $124 price target. With a current valuation multiple at the low end of its historical range and the bottom of the coatings industry peer group, PPG shares are attractive at current prices, Koort tells investors in a research note. The analyst also reiterates a Buy rating on Sherwin-Williams (SHW) while lowering his price target for the shares to $485 from $503. "In this environment of uncertainty, we find the coatings companies better positioned than most chemical equities," says Koort. The analyst points out that coatings demand trends tend to be more stable.
KORS Use CPRI
$47.99

-0.24 (-0.50%)

11/13/18
MKMP
11/13/18
NO CHANGE
Target $52
MKMP
Neutral
Michael Kors price target lowered to $52 from $74 at MKM Partners
MKM Partners analyst Roxanne Meyer lowered her price target on Michael Kors to $52 and kept her Neutral rating after its in-line Q2 revenue and lower than expected Q3 earnings. The analyst adds that the Q2 earnings beat came from the reduced SG&A spending as well as the lower tax rate and that the company's Americas comps and retail gross margins fell short of expectations. Meyer further contends that while she was pleased by the strength in footwear, RTW, and men's segments, along with double-digit gains in mainland China, it was not enough to offset softness in handbags and accessories which she expects to be an overhang for the shares.
11/12/18
MACQ
11/12/18
INITIATION
Target $75
MACQ
Outperform
Michael Kors initiated with an Outperform at Macquarie
Target $75.
11/12/18
11/12/18
UPGRADE

Market Perform
Michael Kors upgraded to Market Perform on valuation at Bernstein
As previously reported, Bernstein analyst Jamie Merriman upgraded Michael Kors to Market Perform from Underperform given a more balanced risk reward profile at current valuation levels. On a fundamental basis, his key concerns regarding the core Michael Kors brand remain, as the brand turnaround remains elusive and as the margin recovery in retail has been difficult to maintain. Comps on a constant currency basis continue to decline, he contends. Without the acquisitions, the analyst expects flat to LSD growth in the Retail and Wholesale segments for the core Kors brand, while the Licensing segment should continue to decline. On the margin front, Merriman notes that management had successfully pulled back on promotions for four quarters, resulting in higher Retail margins, but this has proved short lived.
11/12/18
11/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Starbucks (SBUX) upgraded to Buy from Hold at Argus with analyst John Staszak citing his expectations of "continued revenue growth and new store openings" for the company, forecasting 14% EPS growth and 15% in total returns over the next several years. 2. L Brands (LB) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying while he is not calling for an imminent inflection in the business, he now sees L Brands as the next retail turnaround story poised for positive shift in the "narrative" as the company appears set to begin embracing change with an "all options on the table" mentality. 3. Armstrong World (AWI) upgraded to Neutral from Underperform at BofA/Merrill with analyst John Lovallo saying Armstrong World deserves a higher multiple following the spin-off of Armstrong Flooring in April 2016 and is positive on the company's capital deployment strategy including buybacks, a recently initiated dividend, and tuck-in M&A. 4. Michael Kors (KORS) upgraded to Market Perform from Underperform at Bernstein with analyst Jamie Merriman citing valuation. 5. Crocs (CROX) upgraded to Neutral from Negative at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MYL Mylan
$34.23

-1.53 (-4.28%)

11/06/18
WELS
11/06/18
UPGRADE
WELS
Outperform
Mylan upgraded to Outperform from Market Perform at Wells Fargo
11/06/18
11/06/18
UPGRADE
Target $42

Buy
Mylan upgraded to Buy after 'encouraging' Q3 report at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Jason Gerberry upgraded Mylan to Buy from Neutral, stating that its Q3 report provided encouraging updates regarding several of its business segments. He believes concerns around its broader portfolio look overdone as industry-level generic pricing is showing signs of stabilizing while the company also provided encouraging new product updates. Gerberry added that he views the 20% stock pullback as an attractive opportunity, but trimmed his price target on Mylan shares to $42 from $44 to reflect rebasing of EpiPen and generic Copaxone.
11/06/18
WELS
11/06/18
UPGRADE
Target $40
WELS
Outperform
Wells upgrades Mylan to Outperform, sees more upside after today's rally
Wells Fargo analyst David Maris upgraded Mylan (MYL) to Outperform from Market Perform with an unchanged price target of $40. The stock in afternoon trading is up 18%, or $5.76, to $37.13. Mylan shares have underperformed the S&P 500 Index for the year-to-date, one year, two year, and five year periods and the shares trade at a discount to peer Teva (TEVA), Maris tells investors in a research note titled "Concerns Abound, but Valuation Attractive." The analyst, however, believes Mylan is positioned for near-term outperformance after the company maintained its 2018 earnings guidance. Maris previously saw risk to second half of 2018 estimates, but with today's Q3 results, he now believes the risk to the downside to Q4 estimates is lower than previously thought. Further, Mylan's statement that Q4 guidance can be achieved with or without new approvals "provides some upside to sentiment" if generic Advair or other approvals materialize, says the analyst. Maris thinks that even with today's rally, Mylan shares still have more than 10% additional upside potential to reach fair value.
11/06/18
COWN
11/06/18
NO CHANGE
Target $31
COWN
Market Perform
Mylan business model looks broken, says Cowen
Cowen analyst Ken Cacciatore said Mylan's Q3 results confirm his thesis that the current business model looks broken. He said at some point a new product cycle needs to materialize, but in Mylan's case it hasn't happened in a material enough way. Cacciatore recommends avoiding the shares and he reiterated his Market Perform rating and $31 price target on Mylan.
TWTR Twitter
$32.92

0.43 (1.32%)

10/26/18
OPCO
10/26/18
UPGRADE
OPCO
Outperform
Twitter upgraded to Outperform from Perform at Oppenheimer
10/26/18
UBSW
10/26/18
NO CHANGE
Target $44
UBSW
Buy
Twitter successfully climbing 'wall of worry,' says UBS
UBS analyst Eric Sheridan said Twitter's Q3 report showed very strong ad revenue trends with material quarter-over-quarter ad business growth, stable trends off a strong base in Japan, and continued progress in video. The analyst said the company climbed almost every "wall of worry" of investors concerns and he believes they can outperform over the next 12 months. Sheridan reiterated his Buy rating and $44 price target on Twitter shares.
10/26/18
OPCO
10/26/18
UPGRADE
Target $37
OPCO
Outperform
Twitter upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Jason Helfstein upgraded Twitter to Outperform from Perform, telling investors in a research note that he believes within the scope of Social Media, Twitter shares offer reasonable value with reduced execution risk. Helfstein is optimistic that ad pricing has stabilized and expenses should grow slower than revenue in 2019. He has a $37 price target on the shares.
AAPL Apple
$186.81

-5.42 (-2.82%)

11/14/18
11/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Guggenheim with analyst Robert Cihra saying the average selling price of the iPhone has increased a "dramatic" $220, or 40%, over the past 10 years, reflecting its "growing value to both consumer and business markets." 2. Kellogg (K) downgraded to Neutral from Overweight at JPMorgan with analyst Ken Goldman saying that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." 3. Apollo Global (APO) and Carlyle Group (CG) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Conagra Brands (CAG) downgraded to Underperform from Market Perform at Bernstein with analyst Alexia Howard saying the frozen category has experienced positive growth over the past year, largely led by new product innovation from Conagra and Pinnacle Foods, but this now seems to be running out of steam. 5. Tenneco (TEN) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing its elevated leverage and limited free cash flow conversion in what he views as an increasingly uncertain environment for auto suppliers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/18
LOOP
11/14/18
NO CHANGE
Target $85
LOOP
Buy
Qorvo price target lowered to $85 from $90 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Qorvo (QRVO) to $85 after its reduced Q3 guidance, saying the "softer unit volumes" sold by Apple (AAPL) were "undoubtedly the primary unnamed specific cause". The analyst is keeping his Buy rating on the shares however, stating that the "tier-1 smartphone unit weakness is becoming a common theme" that is generating lesser impact with each news release as evidenced by Qorvo's shares trading flat yesterday. Acree adds that investors should start to "pick their spots for 2019" amid the smartphone industry's start of migration to 5G and believes that Qorvo is "well positioned to continue to gain share at the leading tier-1 handset OEMs".
11/14/18
DADA
11/14/18
NO CHANGE
Target $72
DADA
Neutral
Qorvo price target lowered to $72 from $81 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo (QRVO) to $72 and kept his Neutral rating after the company cut its Q3 earnings guidance to reflect the expectations of a weaker high-end smartphone demand. The analyst believes that the "softer than expected" launch of the new iPhones by Apple (AAPL) has " triggered a rapid change in order flow over the past couple of weeks" and anticipates similar announcements from other Apple suppliers to track reduced guidance by Qorvo and Lumentum (LITE).
11/14/18
ADAM
11/14/18
NO CHANGE
Target $83
ADAM
Buy
Qorvo price target lowered to $83 from $90 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Qorvo (QRVO) to $83 from $90 after the company lowered its guidance, as several Apple (AAPL) suppliers have done. He expects Qorvo to continue focusing on developing integrated solutions to drive dollar content growth faster than the slow growing smartphone market and anticipates improving growth trends as 5G ramps long-term. Walkley reiterated his Buy rating on Qorvo shares.
MU Micron
$38.03

0.17 (0.45%)

10/26/18
10/26/18
DOWNGRADE

Neutral
Western Digital downgraded to Neutral on 'much lower' cycle trough at Longbow
As previously reported, Longbow analyst Joe Wittine downgraded Western Digital (WDC) to Neutral from Buy on the abrupt contraction in earnings power and visibility evident in its December quarter guidance. He reduced his FY19 EPS forecast to $7.00 from $11.30 and his FY20 EPS estimate to $9.10 from $11.50. For Micron (MU), Wittine said he continues to fear the DRAM cycle's eventual unwind will closely resemble the NAND cycle's unwind over the last year, "leaving the shares exposed" no matter how inexpensive. For Seagate (STX), Wittine sees Western Digital's more cautious view as "the flashing yellow we have been awaiting," but he added that Seagate's downside isn't "crystal clear given his view that a combination of Seagate and Toshiba consolidated share that Western Digital likely lost during the quarter.
11/12/18
DBAB
11/12/18
NO CHANGE
Target $60
DBAB
Buy
Micron shares look attractively valued, says Deutsche Bank
With shares of Micron Technology trading at a low price-to-earnings multiple of four-to-five times for much of the past 12 months, it is obvious that the market is pricing in consensus earnings estimates will have to come down, Deutsche Bank analyst Sidney Ho tells investors in a research note. The analyst sees the key questions as being: are the expected earnings cuts deep enough, and what multiple should be assigned to a trough earnings estimate? Following an analysis, Ho concludes that the stock appears to be trading at a normalized P/E multiple on this "trough" earnings. This makes Micron shares look attractively valued, Ho says. He maintains a Buy rating on Micron with a $60 price target. The stock closed Friday down 3%, or $1.33, to $39.11.
10/31/18
KEYB
10/31/18
NO CHANGE
KEYB
DRAM, NAND contract pricing accelerates down as expected, says KeyBanc
inSpectrum released its October monthly memory contract pricing this morning and DRAM contract pricing for 8Gb DDR4 was down 4.7% month-over-month and up 11.0% year-over-year, KeyBanc analyst Weston Twigg tells investors in a research note. He says this is consistent with his prior expectation for DRAM contract price declines to accelerate in Q4 and Q1 as additional supply comes online at Samsung and as demand softens related to inventory destocking. Further, according to inSpectrum, NAND contract pricing for 128Gb TLC was down 10.4% month-over-month and down 52% year-over-year, with pricing now below mid-2016 levels, Twigg point out. The analyst, however, does not expect "extreme price declines" and anticipates price stabilization in the second half of 2019. Twigg continues to anticipate "strong demand tailwinds" for both DRAM and NAND over the next few years. This should provide "plenty of opportunity" for memory producers Micron Technology (MU), Seagate (STX) and Western Digital (WDC), says the analyst.
10/25/18
STFL
10/25/18
NO CHANGE
STFL
Hynix outlook should ease fears of extended memory downturn, says Stifel
SK Hynix in last night's Q3 earnings report saw a sequential increase in gross margin with slightly higher DRAM average selling prices quarter-over-quarter while NAND Flash selling prices s declined at roughly the same rate as in Q2, Stifel analyst Kevin Cassidy tells investors in a research note. Importantly, Hynix expects the current pricing pressure to have a short duration with customers decreasing NAND flash inventories by the end of 2018 and data center DRAM demand re-accelerating in mid-2019, says Cassidy. He believes the company's outlook and the "rational response" to the pricing environment should alleviate some market concerns about an extended downturn in the memory cycle. This benefits suppliers such as Micron Technology (MU), Smart Global Holdings (SGH) and Western Digital (WDC), Cassidy tells investors. Shares of Micron in early trading are up 49c to $35.92.
CLPR Clipper Realty
$14.00

-0.05 (-0.36%)

IAC IAC
$180.60

-4.9 (-2.64%)

11/07/18
JEFF
11/07/18
NO CHANGE
Target $70
JEFF
Buy
Match a buy on selloff despite 'head scratcher' dividend, says Jefferies
Jefferies analyst Brent Thill says that while Match Group's (MTCH) "slightly underwhelming" Q4 guidance is a negative, the "majority of the softness is external rather than fundamental." However, the analyst calls the special dividend a "head scratcher" and believes "one may surmise that IAC (IAC) has intentions to do something with the cash." Nonetheless, Thill is a buyer of Match Group on today's weakness and remains positive on the name long-term. The analyst has a Buy rating on the shares with $70 price target.
11/09/18
BNCH
11/09/18
NO CHANGE
Target $260
BNCH
Buy
IAC pullback presents attractive entry point, says Benchmark
Benchmark analyst Daniel Kurnos views the pullback in IAC (IAC) shares following its earnings report as an attractive entry point, stating that he sees the breaking out both Dotdash and Vimeo going forward as presenting the potential for a "cleaner" core valuation. He also sees Angi Homeservices (ANGI) having upside going forward and thinks Match (MTCH) will potentially bottom out after what he views as an overreaction to its guidance. Kurnos keeps a Buy rating on IAC shares with a $260 price target.
11/09/18
BMOC
11/09/18
NO CHANGE
Target $282
BMOC
Outperform
IAC price target raised to $282 from $265 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on IAC (IAC) to $282 and kept his Outperform rating after its Q3 earnings beat along with strong performance coming from its ANGI Homeservices (ANGI) and Match Group (MTCH) holdings. The analyst is also positive on the improving execution of IAC'c Vimeo business, accelerating Dotdash, and more mobile-driven sales at Apalon.
10/12/18
10/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Comcast (CMCSA) reinstated with an Overweight at JPMorgan. 2. Abeona Therapeutics (ABEO) initiated with a Buy at Mizuho. 3. Foamix (FOMX) initiated with an Overweight at Cantor Fitzgerald. 4. Match Group (MTCH) and IAC (IAC) were initiated with a Buy at Nomura Instinet while Angi Homeservices (ANGI) was initiated with a Neutral at Nomura Instinet. 5. Terex (TEX) initiated with a Neutral at Longbow. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ADNT Adient
$24.13

-0.36 (-1.47%)

11/14/18
11/14/18
DOWNGRADE
Target $30

Underweight
Tenneco downgraded to Underweight in 'uncertain environment' at Morgan Stanley
As previously reported, Morgan Stanley analyst Armintas Sinkevicius downgraded Tenneco (TEN) to Underweight from Equal Weight given its elevated leverage and limited free cash flow conversion in what he views as an increasingly uncertain environment for auto suppliers. He believes the stock is unlikely to be viewed more favorably by the market until the spin of the Aftermarket & Ride Performance business in late 2019, "at best." Sinkevicius lowered his price target on Tenneco shares to $30 from $40. On the group in general, the analyst noted that Q3 results were disappointing compared to consensus estimates and he believes there will be limited support for the stocks until there is more clarity around China and until guidance for 2019 is "de-risked." Sinkevicius also lowered his price targets for Adient (ADNT), Aptiv (APTV), American Axle (AXL), BorgWarner (BWA), Delphi Technologies (DLPH), Goodyear Tire (GT), Lear (LEA), Magna (MGA) and Visteon (VC).
10/17/18
WELS
10/17/18
NO CHANGE
Target $30
WELS
Market Perform
Adient price target lowered to $30 from $50 at Wells Fargo
Wells Fargo analyst Richard Kwas lowered his price target for Adient to $30 from $50 ahead of quarterly results. The analyst reiterates a Market Perform rating on the shares.
11/12/18
UBSW
11/12/18
NO CHANGE
Target $50
UBSW
Buy
Adient weakness a buying opportunity, says UBS
UBS analyst Colin Langan noted Adient reported Q4 results in line with their preannouncement but said its dividend cut and debt covenant adjustment likely led to liquidity concerns and drove the share decline. The analyst believes the selloff is overdone and little has changed with the company. He believes the issues are largely isolated to a handful of plants and future launches and there is no glaring level of uncompetitiveness. Langan reiterated his Buy rating and $50 price target on Adient shares.
11/12/18
RBCM
11/12/18
NO CHANGE
Target $21
RBCM
Sector Perform
Adient price target lowered to $21 from $30 at RBC Capital
RBC Capital analyst Joseph Spak lowered his price target on Adient to $21 and kept his Sector Perform rating after its Q4 results. The analyst believes that operational issues at the company will persist and that FY18 is not the bottom, forecasting FY19 EBITDA to fall another 15%. Spak points to Adient's high leverage, suspended dividend, and feedback from its customers that suggest the possibility of reduced future growth.
GM General Motors
$35.23

-0.7 (-1.95%)

10/29/18
GSCO
10/29/18
UPGRADE
Target $12
GSCO
Buy
Goldman upgrades Ford to Buy with 40% total return potential in 12 months
Goldman Sachs analyst David Tamberrino upgraded Ford Motor (F) to Buy and raised his price target for the shares to $12 from $9. While the analyst still expects a "downward earnings trajectory" into 2019 as North America profit remains under pressure, he believes next year will represent "trough earnings" for Ford. The combination of a refreshed product cadence globally as well as cost improvements from strategic initiatives will begin to take hold in 2019, Tamberrino tells investors in a research note. The analyst believes Ford "can put itself on a pathway to earnings that are above normalized EPS by 2021." With investor sentiment still skewed toward General Motors (GM) over Ford, incremental announcements regarding plant closures and business decisions around under-performing product lines would likely be viewed positively, says Tamberrino. In addition, he believes Ford's current regular dividend "appears manageable." All in, he sees potential for a total return of approximately 40% over the next year for Ford shares. The stock in premarket trading is up 25c to $9.23.
11/01/18
JPMS
11/01/18
NO CHANGE
Target $48
JPMS
Overweight
JPMorgan sees 'lots more upside' in General Motors shares
General Motors says a "well-deserved" 9% rally yesterday after reporting "much better than expected profits and did so in ways that suggest the good times are likely to continue," JPMorgan analyst Ryan Brinkman tells investors in a post-earnings research note. The analyst raised his 2018, 2019, and 2020 estimates, on flow-through of the stronger trends evident in Q3. He reiterates an Overweight rating on the shares and sees 31% upside to his $48 December 2019 price target. Brinkman says he sees "lots more upside" in the stock.
11/01/18
UBSW
11/01/18
NO CHANGE
Target $52
UBSW
Buy
General Motors firing on all cylinders, says UBS
UBS analyst Colin Langan noted General Motors reported better than expected Q3 results and said management continues to believe that Q4 will be the strongest quarter. The analyst said he remains cautious given the China macro outlook, mark-to-the-market risks of the PSA warrants, and Cruise spending. He notes, however, that GM Financial continues to hit record performance and will pay out a $375M dividend. Langan reiterated his Buy rating and $52 price target on GM shares.
10/23/18
10/23/18
NO CHANGE

Buy
Citi lays out stages to potentially get GM shares to $76-$134 range
The recent pullback in General Motors "underscores the urgency to address perception gaps that have long plagued the stock," Citi analyst Itay Michaeli tells investors in a research note. The analyst believes GM management remains open to considering new ideas. Michaeli lays out three stages that he thinks, over time, could potentially take GM shares to $76-$134. The first stage would involve GM re-segmenting its Pickup Truck Franchise away from the "Global Traditional Auto Franchise," and then re-messaging the Pickup Franchise using "years of compelling data that support far higher multiples," the analyst writes. The next stage, according to Michaeli, is a Cruise autonomous vehicle launch by 2020. The third stage, to take place between 2019 and 2025, would be unlocking the "unique turnaround story embedded in GM's profitable but under-earning Global Traditional Auto Franchise."
PRGO Perrigo
$63.47

-1.98 (-3.03%)

11/13/18
BREN
11/13/18
DOWNGRADE
Target $72
BREN
Hold
Perrigo downgraded to Hold from Buy at Berenberg
Berenberg analyst Patrick Trucchio downgraded Perrigo to Hold and cut his price target for the shares to $72 from $100.
11/14/18
WELS
11/14/18
NO CHANGE
Target $64
WELS
Market Perform
Perrigo price target lowered to $64 form $77 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Perrigo to $64 from $77 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/18
BREN
11/13/18
DOWNGRADE
Target $72
BREN
Hold
Berenberg downgrades Perrigo to Hold, cuts target to $72 from $100
Berenberg analyst Patrick Trucchio downgraded Perrigo to Hold from Buy and cut his price target for the shares to $72 from $100. The shares closed yesterday up $1.51 to $65.58. Although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines," Trucchio tells investors in a research note. Secular challenges in U.S. generics, including increased competition and reduced pricing driven by greater efficiencies at FDA and buyer consolidation, are unlikely to ease, says the analyst. He says Perrigo is not as immune to secular challenges in U.S. generics as he once believed. Further, the company's supply chain issues and poor execution are adding to these challenges, Trucchio contends.
VOYA Voya Financial
$45.04

-0.46 (-1.01%)

11/01/18
RBCM
11/01/18
NO CHANGE
Target $55
RBCM
Outperform
Voya Financial price target lowered to $55 from $60 at RBC Capital
RBC Capital analyst Mark Dwelle lowered his price target on Voya Financial to $55 to reflect the "actuarial adjustment" in Q3 and the assumption of 1-times estimated 2019 book value vs. 1.1-times prior amid declining multiples across the sector. The analyst also keeps his Outperform rating on the shares and sees the recent pullback as an "excellent opportunity" to participate in Voya Financal's "positively changing business model". Dwelle adds that he looks ahead to the company's strategic updates at its upcoming investor day.
06/20/18
06/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tableau (DATA) initiated with a Neutral at Susquehanna. 2. Voya Financial (VOYA) reinstated with a Neutral at Goldman Sachs. 3. RBC Bearings (ROLL) initiated with a Hold at SunTrust. 4. Castlight Health (CSLT) initiated with an Outperform at William Blair. 5. CommScope (COMM) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/18
SBSH
07/11/18
NO CHANGE
SBSH
Neutral
Citi questions if Athene Holding shares can ever outperform
Citi analyst Suneet Kamath keeps a Neutral rating on Athene Holding in a research note titled "If ATH Can't Outperform in the Current Environment, Can it Ever?" The stock should be outperforming in the current environment given its "continued capital optionality," upside potential from the Voya Financial (VOYA) deal and a "benign" credit environment, Kamath tells investors in a research note. The analyst adds: "The fact that it is not raises the question: can it ever?" Kamath estimates Athene's tax rate advantage has gone from 20-21 points to 5-6 points. He also believes the company's offshore strategy might soon be replicated "by yet another company," creating more competition in the market and among investors. Kamath sees more attractive opportunities elsewhere in the Insurance space.
11/13/18
BTIG
11/13/18
NO CHANGE
Target $59
BTIG
Buy
Voya Financial updated guidance should be well received by investors, says BTIG
BTIG analyst Mark Palmer notes that Voya Financial, in conjunction with its Investor Day, announced new guidance of annual adjusted operating earnings per share growth of at least 10% through 2021, which should be achieved through a combination of organic growth, cost savings and capital deployment. The analyst believes the company's self-help efforts have been at the core of its earnings growth and share price appreciation during the past few years. Palmer expects the company's updated guidance will be well received by investors. He has a Buy rating and $59 price target on the shares.
MDCO The Medicines Co.
$20.82

-1.97 (-8.64%)

06/06/18
RILY
06/06/18
INITIATION
Target $55
RILY
Buy
The Medicines Co. initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started The Medicines Co. with a Buy rating and $55 price target. The analyst believes the company has a "disruptive" cholesterol drug with "de-risked safety."
08/20/18
SBSH
08/20/18
NO CHANGE
Target $50
SBSH
Buy
The Medicines Co. price target raised to $50 from $40 at Citi
Citi analyst Joel Beatty raised his price target on The Medicines Co. shares to $50 as he believes the ongoing phase 3 inclisiran trial will be a success and that the drug can take significant share, if approved, because its every 6 month dosing is a significant advantage over current PCSK9s that must be dosed monthly. He also notes that sales of the two approved PCSK9 agents are accelerating and believes new cholesterol treatment guidelines will likely further drive longer-term PCSK9 growth, Beatty tells investors. He keeps a Buy rating on Medicines Co. shares.
01/24/18
01/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Valeant (VRX) initiated with a Sell at Goldman Sachs. 2. trivago (TRVG) initiated with a Hold at SunTrust. 3. Holly Energy (HEP) initiated with a Hold at Jefferies. 4. Aramark (ARMK) reinstated with an Outperform at Credit Suisse. 5. The Medicines Co. (MDCO) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/24/18
JPMS
01/24/18
INITIATION
Target $45
JPMS
Overweight
The Medicines Co. reinstated with an Overweight at JPMorgan
JPMorgan analyst Jessica Fye reinstated The Medicines Co. with an Overweight rating and $45 price target following a period of restriction. The analyst sees "substantial potential upside in the stock over time" but notes 2018 is largely an execution year.
AER AerCap
$51.85

-0.06 (-0.12%)

03/13/18
MACQ
03/13/18
INITIATION
Target $62
MACQ
Outperform
AerCap initiated with an Outperform at Macquarie
Macquarie initiated AerCap with an Outperform and $62 price target.
03/14/18
MACQ
03/14/18
INITIATION
Target $62
MACQ
Outperform
AerCap initiated with an Outperform entering growth phase, says Macquarie
Macquarie analyst Susan Donofrio initiated AerCap with an Outperform and $62 price target. Donofrio believes the company is entering a new growth phase, with scale and relationships that give it a competitive advantage, and will maintain a share-holder friendly capital allocation strategy.
07/31/18
SPHN
07/31/18
DOWNGRADE
SPHN
Equal Weight
AerCap downgraded to Equal Weight from Overweight at Stephens
07/31/18
07/31/18
DOWNGRADE
Target $64

Equal Weight
AerCap downgraded to Equal Weight after outperformance at Stephens
As previously reported, Stephens analyst Vincent Caintic downgraded AerCap (AER) to Equal Weight from Overweight, noting that the stock has outperformed both Air Lease (AL) and Aircastle (AYR) year-to-date. Caintic is finding it more difficult for AerCap to show core EPS growth without "lofty assumptions" and prefers Aer Lease, which he thinks can continue with double-digit EPS growth year-over-year. He maintains a $64 price target on AerCap shares.
GRBK Green Brick
$8.70

-0.15 (-1.69%)

08/24/18
FBCO
08/24/18
INITIATION
Target $9
FBCO
Neutral
Green Brick initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari started Green Brick Partners with a Neutral rating and $9 price target. As supply constraints and inflation persist, the company's margins could be increasingly under pressure, Maklari tells investors in a research note. She believes the current valuation properly captures Green Brick's risk/reward profile.
08/09/18
SBSH
08/09/18
UPGRADE
Target $12
SBSH
Buy
Green Brick upgraded to Buy from Neutral at Citi
Citi analyst Scott Schrier upgraded Green Brick Partners to Buy and raised his price target for the shares to $12 from $11. The company posted "solid progress" with Q2 EBT and net orders above expectations, Schrier tells investors in a post-earnings research note. The analyst believes Green Brick is executing well in some of the best markets.
06/19/18
SBSH
06/19/18
INITIATION
Target $13
SBSH
Neutral
Green Brick assumed with a Neutral at Citi
Citi analyst Scott Schrier assumed coverage of Green Brick Partners with a Neutral rating and $13 price target. The analyst took over coverage of the Building Products, Construction Materials group.
02/20/18
02/20/18
UPGRADE
Target $13

Outperform
Green Brick upgraded to Outperform at JMP Securities
As previously reported, JMP Securities analyst Peter Martin upgraded Green Brick to Outperform from Market Perform citing greater visibility on its Atlanta operations and growth prospects in Texas with its recent Frisco land acquisition. The analyst, who contends Green Brick shares are currently undervalued, set a $13 price target on the stock.
ESV Symbol changed to VAL
$6.15

0.1 (1.65%)

10/17/18
JRCO
10/17/18
UPGRADE
JRCO
Buy
Ensco upgraded to Buy from Accumulate at Johnson Rice
10/12/18
10/12/18
NO CHANGE

Societe Generale cuts Weatherford to sell amid oil services rating shake-up
As previously reported, Societe Generale analyst Edward Muztafago made several ratings changes in the oil services space as he recommended rotating more fully into offshore and reducing U.S. land exposure. He views U.S. activity being poised for constrained growth following an anticipated recovery from "the current frac malaise," while believing offshore activity appears set to inflect, Muztafago tells investors. With that backdrop view, he upgraded Ensco (ESV), Noble Corp. (NE) and Oceaneering (OII), all to Buy from Hold, downgraded Halliburton (HAL) to Hold from Buy and lowered his rating on Weatherford (WFT) to Sell from Buy. Current U.S. challenges and the "stock market meltdown" create risk to Weatherford's asset divestiture plans that investors are so concerned about and "stumbles may not be well received," Muztafago stated.
10/12/18
JPMS
10/12/18
UPGRADE
Target $8
JPMS
Neutral
Ensco upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Sean Meakim upgraded Ensco (ESV) to Neutral with an $8 price target to reflect the announced all-stock merger agreement with Rowan Companies (RDC).
10/30/18
DNBM
10/30/18
UPGRADE
DNBM
Hold
Ensco upgraded to Hold from Sell at DNB Markets

TODAY'S FREE FLY STORIES

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$19.94

0.16 (0.81%)

17:57
08/16/19
08/16
17:57
08/16/19
17:57
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Trian Fund lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BRY

Berry Petroleum

$8.59

0.39 (4.76%)

17:54
08/16/19
08/16
17:54
08/16/19
17:54
Syndicate
Breaking Syndicate news story on Berry Petroleum »

Berry Petroleum files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSWI

CSW Industrials

$70.20

1.92 (2.81%)

17:52
08/16/19
08/16
17:52
08/16/19
17:52
Hot Stocks
CSW Industrials CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$3.03

0.135 (4.66%)

17:49
08/16/19
08/16
17:49
08/16/19
17:49
Hot Stocks
Oasis Petroleum CEO buys 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EE

El Paso Electric

$66.41

0.005 (0.01%)

17:45
08/16/19
08/16
17:45
08/16/19
17:45
Hot Stocks
El Paso Electric director Wertheimer sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$165.07

2.81 (1.73%)

17:42
08/16/19
08/16
17:42
08/16/19
17:42
Hot Stocks
Honeywell CEO sells 7.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.08

0.01 (0.93%)

17:37
08/16/19
08/16
17:37
08/16/19
17:37
Earnings
Moleculin Biotech reports Q2 EPS (3c), two estimates (10c) »

CFO Jonathan Foster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.13

0.0046 (3.59%)

17:35
08/16/19
08/16
17:35
08/16/19
17:35
Syndicate
Breaking Syndicate news story on Viveve »

Viveve files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$46.21

0.535 (1.17%)

17:30
08/16/19
08/16
17:30
08/16/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Perrigo »

Starboard lowers Perrigo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UAL

United Continental

$82.96

1.36 (1.67%)

17:28
08/16/19
08/16
17:28
08/16/19
17:28
Hot Stocks
United Continental director Shapiro buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

MBIO

Mustang Bio

$3.88

0.19 (5.15%)

17:26
08/16/19
08/16
17:26
08/16/19
17:26
Syndicate
Breaking Syndicate news story on Mustang Bio »

Mustang Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

BCLI

BrainStorm

$3.63

0.055 (1.54%)

17:24
08/16/19
08/16
17:24
08/16/19
17:24
Syndicate
Breaking Syndicate news story on BrainStorm »

BrainStorm files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$61.27

0.66 (1.09%)

17:15
08/16/19
08/16
17:15
08/16/19
17:15
Hot Stocks
Westlake Chemical raises quarterly dividend by 5% to 26.25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIG

GigCapital

$10.30

(0.00%)

17:10
08/16/19
08/16
17:10
08/16/19
17:10
Hot Stocks
GigCapital receives noncompliance notice from NYSE »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.